Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher-yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf, and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. 
Company Growth (employees)
Davis, US
Size (employees)
57 (est)
Arcadia Biosciences was founded in 2015 and is headquartered in Davis, US

Key People/Management at Arcadia Biosciences

Vic Knauf

Vic Knauf

Chief Scientific Officer
Zhongjin Lu

Zhongjin Lu

Vice President of Product Development
Don Emlay

Don Emlay

Vice President of Regulatory Affairs

Arcadia Biosciences Office Locations

Arcadia Biosciences has an office in Davis
Davis, US (HQ)
105 202 Cousteau Pl

Arcadia Biosciences Financials and Metrics

Arcadia Biosciences Financials

Arcadia Biosciences's revenue was reported to be $3.2 m in FY, 2016

Revenue (Q2, 2017)

991 k

EBIT (Q2, 2017)

(3.7 m)

Market capitalization (13-Dec-2017)

9.7 m

Cash (30-Jun-2017)

13.4 m
Arcadia Biosciences's current market capitalization is $9.7 m.
USDFY, 2015FY, 2016


5.4 m3.2 m

Revenue growth, %


R&D expense

9 m8.7 m

General and administrative expense

11.1 m12.3 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


815 k1.4 m1.8 m852 k721 k1.1 m1 m991 k

R&D expense

1.8 m2.1 m3.2 m2.2 m2.2 m2.3 m1.8 m1.7 m

General and administrative expense

2.6 m2.8 m2.8 m3.4 m2.8 m2.7 m3.1 m2.9 m

Operating expense total

4.5 m5 m6.1 m5.8 m5 m5 m5 m4.7 m
USDFY, 2015FY, 2016


24 m2 m

Accounts Receivable

706 k349 k


692 k877 k

Current Assets

52 m52.2 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


11.3 m80 m63 m29.5 m27.4 m10.5 m7.6 m13.4 m

Accounts Receivable

150 k145 k685 k587 k177 k97 k284 k432 k

Current Assets

12.4 m81.6 m76.6 m52.5 m56.2 m55.7 m50.4 m46.5 m


663 k633 k597 k656 k636 k580 k486 k417 k
USDFY, 2015FY, 2016

Net Income

(18 m)(19.6 m)

Depreciation and Amortization

294 k304 k

Accounts Receivable

336 k357 k


412 k582 k
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(5.2 m)(4.6 m)(4.2 m)

Accounts Receivable

150 k145 k685 k587 k177 k97 k284 k

Accounts Payable

3.4 m4.7 m4 m2.8 m2.6 m2.6 m2.2 m
Y, 2017

Financial Leverage

3.3 x
Show all financial metrics

Arcadia Biosciences Market Value History

Arcadia Biosciences's Web-traffic and Trends

Arcadia Biosciences Company Life and Culture

You may also be interested in